Atrial fibrillation Atrial fibrillation
Conditions
Interventions
Administration of normal saline solution for 3 hours immediately following the procedure
Administration of normal saline
Sponsors
Okamatsu Hideharu
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients undergoing their first atrial fibrillation ablation at our hospital using the Farapulse system or PulseSelect system
Exclusion criteria
Exclusion criteria: Patients meeting any of the following criteria: Patients currently participating in other clinical trials or clinical research (interventional studies) Left ventricular ejection fraction ==400 pg/ml Left atrial diameter >=55 mm Long-standing persistent atrial fibrillation lasting >=3 years Renal impairment with serum creatinine >=1.5 mg/dl Post-valvular surgery(including catheter-based treatment) Post-Maze surgery Severe valvular heart disease Active malignant neoplasms Patients who underwent Pulsed Field Ablation treatment for reasons other than pulmonary vein isolation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Degree of increase in free hemoglobin at T2, T3, and T4 Degree of increase in creatinine at T2, T3, and T4 Incidence of Stage 1 or higher kidney injury according to KDIGO clinical guidelines | — |
Secondary
| Measure | Time frame |
|---|---|
| Degree of elevation in total bilirubin and LDH in T2, T3, and T4 Degree of decrease in serum hemoglobin in T2, T3, and T4 Degree of elevation in BUN in T2, T3, and T4 Frequency of patients with haptoglobin levels falling below the detection limit on the day after surgery | — |
Contacts
Public ContactHideharu Okamatsu
Saiseikai Kumamoto Hospital
Outcome results
None listed